Early Post-Discharge Bleeding and Antiplatelet Therapy Discontinuation Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention

In our study, patients who did not have a follow-up outpatient appointment arranged before discharge were less likely to report their bleeding event to a clinician. [...]ensuring early clinical follow-up--particularly for patients at higher risk of bleeding (e.g., women, lower baseline functional status, discharge on a second-generation ADPri regimen, or concurrent oral anticoagulant prescription)--might be a key first step in both raising subsequent bleeding events to clinical attention and avoiding premature ADPri discontinuation. [...]bleeding occurs commonly in the early period after discharge among MI patients treated with PCI and ADPris and is not always brought to clinical attention.